Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Bent Ascanius, Jacobsen"'
Autor:
Lone Larsen, Anastasia Karachalia Sandri, Jan Fallingborg, Bent Ascanius Jacobsen, Henrik Albæk Jacobsen, Martin Bøgsted, Asbjørn Mohr Drewes, Tine Jess
Publikováno v:
Larsen, L, Karachalia Sandri, A, Fallingborg, J, Jacobsen, B A, Jacobsen, H A, Bøgsted, M, Drewes, A M & Jess, T 2023, ' Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978-2020 ', The American Journal of Gastroenterology, vol. 118, no. 3, pp. 501-510 . https://doi.org/10.14309/ajg.0000000000002187
INTRODUCTION: While the incidence of inflammatory bowel disease (IBD) is rising globally, it has been suggested to stabilize in westernized countries, but this has not yet been shown in exhaustive and large cohorts. We generated an IBD cohort in Nort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563d25d0b274fa355dd9ba81623f0baf
https://vbn.aau.dk/da/publications/0b14fe9e-07b2-4e8e-84df-b6456597a630
https://vbn.aau.dk/da/publications/0b14fe9e-07b2-4e8e-84df-b6456597a630
Autor:
Lone Heimann Larsen, Dalia Saleh Karzoun, Bent Ascanius Jacobsen, Jan Fallingborg, Tine Jess, Asbjørn Mohr Drewes, Hanna Bjarkhamar Poulsen
Publikováno v:
Larsen, L, Drewes, A M, Fallingborg, J, Jacobsen, B A, Karzoun, D S, Poulsen, H B & Jess, T 2020, ' Discontinuing Infliximab in Benign Crohn’s Disease : A Real-Life Population-Based Cohort Study ', Advanced Research in Gastroenterology & Hepatology, vol. 15, no. 1, 555905, pp. 0089-0095 . https://doi.org/10.19080/ARGH.2020.15.555905
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cda38248c4fb6b1bdced6ac505bc904
https://vbn.aau.dk/da/publications/68b5db6f-fb04-448c-9e26-2c7040b71250
https://vbn.aau.dk/da/publications/68b5db6f-fb04-448c-9e26-2c7040b71250
Autor:
Lone Larsen, Tine Jess, Asbjørn Mohr Drewes, Jan Fallingborg, Thomas Bo Jensen, Bent Ascanius Jacobsen, Marie Christine Hede Broberg
Publikováno v:
Larsen, L, Drewes, A M, Broberg, M C H, Fallingborg, J, Jacobsen, B A, Jensen, T B & Jess, T 2018, ' Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease : A Population-Based Cohort Study, 1999-2014 ', Inflammatory Bowel Diseases, vol. 24, no. 2, pp. 433-439 . https://doi.org/10.1093/ibd/izx038
Background: Long-term data on real life use of infliximab (IFX) for inflammatory bowel disease (IBD) are lacking. We studied prescription patterns during the first 16 years following marketing authorization.Methods: In a population-based cohort from
Autor:
T. Jess, Bent Ascanius Jacobsen, Bitten Aagaard, Lone Larsen, Anders Dige, Jan Fallingborg, Jørgen Agnholt, Asbjørn Mohr Drewes
Publikováno v:
Larsen, L, Jess, T, Drewes, A M, Dige, A, Fallingborg, J, Jacobsen, B A, Aagaard, B & Agnholt, J 2019, ' Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatment ', European Journal of Gastroenterology and Hepatology, vol. 31, no. 8, pp. 964-967 . https://doi.org/10.1097/MEG.0000000000001440
ObjectiveLoss of infliximab (IFX) effect is a clinical challenge in the management of patients with Crohn's disease (CD), but this can potentially be reduced with azathioprine (AZA) or with corticosteroids (CS). We aimed to study whether CS premedica
Autor:
Bent Ascanius Jacobsen, Lars L. Thomsen, Janneke van der Woude, Stefan Lindgren, Jens Frederik Dahlerup, Lars Åke Bark
Publikováno v:
Scandinavian Journal of Gastroenterology, 51(11), 1332-1338. Informa Healthcare
Dahlerup, J F, Jacobsen, B A, van der Woude, J, Bark, L-Å, Thomsen, L L & Lindgren, S 2016, ' High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23 ', Scandinavian Journal of Gastroenterology, vol. 51, no. 11, pp. 1332-1338 . https://doi.org/10.1080/00365521.2016.1196496
Scandinavian Journal of Gastroenterology
Dahlerup, J F, Jacobsen, B A, van der Woude, C J, Bark, L-Å, Thomsen, L & Lindgren, S 2016, ' High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23 ', Scandinavian Journal of Gastroenterology, vol. 51, no. 11, pp. 1332-8 . https://doi.org/10.1080/00365521.2016.1196496
Dahlerup, J F, Jacobsen, B A, van der Woude, J, Bark, L-Å, Thomsen, L L & Lindgren, S 2016, ' High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23 ', Scandinavian Journal of Gastroenterology, vol. 51, no. 11, pp. 1332-1338 . https://doi.org/10.1080/00365521.2016.1196496
Scandinavian Journal of Gastroenterology
Dahlerup, J F, Jacobsen, B A, van der Woude, C J, Bark, L-Å, Thomsen, L & Lindgren, S 2016, ' High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23 ', Scandinavian Journal of Gastroenterology, vol. 51, no. 11, pp. 1332-8 . https://doi.org/10.1080/00365521.2016.1196496
Objective: Iron isomaltoside (Monofer®) is a high-dose intravenous iron preparation with good tolerability and efficacy in inflammatory bowel disease (IBD) patients with iron deficiency anaemia (IDA). This trial evaluates the safety and efficacy, in
Autor:
Kai G Kahl, Povl Munk-Jørgensen, Christina Engelke, Jens Ivar Larsen, Kenji J. Tsuchiya, Karel Frasch, Bent Ascanius Jacobsen, Christoph Lauber, Signe O Wallenstein-Jensen, Stephanie Peter, Graziella Giacometti Bickel, Birthe Mogensen, Ulla A Andersen, Joachim Cordes, Christian Lange-Asschenfeldt, Jørgen Achton Nielsen, Kristian L Toftegaard, Bernhard Bork, Wulf Rössler, Richard Uwakwe
Publikováno v:
Engelke, C, Lange-Asschenfeldt, C, Peter, S, Kahl, K G, Frasch, K, Larsen, J I, Bickel, G G, Bork, B, Jacobsen, B A, Wallenstein-Jensen, S O, Lauber, C, Mogensen, B, Nielsen, J A, Rössler, W, Tsuchiya, K J, Toftegaard, K L, Andersen, U A, Uwakwe, R, Munk-Jørgensen, P & Cordes, J 2018, ' A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment : The international study on physical illness in mentally ill ', European Psychiatry, vol. 48, pp. 65-70 . https://doi.org/10.1016/j.eurpsy.2017.11.004
Engelke, C, Lange-Asschenfeldt, C, Peter, S, Kahl, K G, Frasch, K, Larsen, J I, Bickel, G G, Bork, B, Jacobsen, B A, Wallenstein-Jensen, S O, Lauber, C, Mogensen, B, Nielsen, J A, Rössler, W, Tsuchiya, K J, Toftegaard, K L, Andersen, U A, Uwakwe, R, Munk-Jørgensen, P & Cordes, J 2018, ' A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill ', European Psychiatry, vol. 48, pp. 65-70 . https://doi.org/10.1016/j.eurpsy.2017.11.004
Engelke, C, Lange-Asschenfeldt, C, Peter, S, Kahl, K G, Frasch, K, Larsen, J I, Bickel, G G, Bork, B, Jacobsen, B A, Jensen, S O W, Lauber, C, Mogensen, B, Nielsen, J A, Rössler, W, Tsuchiya, K J, Toftegaard, K L, Andersen, U A, Uwakwe, R, Munk-Jørgensen, P & Cordes, J 2018, ' A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill ', European Psychiatry, vol. 48, pp. 65-70 . https://doi.org/10.1016/j.eurpsy.2017.11.004
Engelke, C, Lange-Asschenfeldt, C, Peter, S, Kahl, K G, Frasch, K, Larsen, J I, Bickel, G G, Bork, B, Jacobsen, B A, Wallenstein-Jensen, S O, Lauber, C, Mogensen, B, Nielsen, J A, Rössler, W, Tsuchiya, K J, Toftegaard, K L, Andersen, U A, Uwakwe, R, Munk-Jørgensen, P & Cordes, J 2018, ' A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill ', European Psychiatry, vol. 48, pp. 65-70 . https://doi.org/10.1016/j.eurpsy.2017.11.004
Engelke, C, Lange-Asschenfeldt, C, Peter, S, Kahl, K G, Frasch, K, Larsen, J I, Bickel, G G, Bork, B, Jacobsen, B A, Jensen, S O W, Lauber, C, Mogensen, B, Nielsen, J A, Rössler, W, Tsuchiya, K J, Toftegaard, K L, Andersen, U A, Uwakwe, R, Munk-Jørgensen, P & Cordes, J 2018, ' A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill ', European Psychiatry, vol. 48, pp. 65-70 . https://doi.org/10.1016/j.eurpsy.2017.11.004
Weight gain among psychiatric inpatients is a widespread phenomenon. This change in body mass index (BMI) can be caused by several factors. Based on recent research, we assume the following factors are related to weight gain during psychiatric inpati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::832d2419febe6460abb376f100bbf5b2
https://www.zora.uzh.ch/id/eprint/222409/
https://www.zora.uzh.ch/id/eprint/222409/
Autor:
Bent Ascanius Jacobsen, Niels Qvist, Jan Nielsen, Bente Mertz Nørgård, Jens Kjeldsen, Kirsten Fonager
Publikováno v:
Nørgård, B M, Nielsen, J, Fonager, K, Kjeldsen, J, Jacobsen, B A & Qvist, N 2014, ' The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) : Based on nationwide Danish registry data ', Journal of Crohn's and Colitis, vol. 8, no. 10, pp. 1274–1280 . https://doi.org/10.1016/j.crohns.2014.03.006
Nørgård, B M, Nielsen, J, Fonager, K, Kjeldsen, J, Jacobsen, B A & Qvist, N 2014, ' The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012)-Based on nationwide Danish registry data ', Journal of Crohn's and Colitis, vol. 8, no. 10, pp. 1274-1280 . https://doi.org/10.1016/j.crohns.2014.03.006
Nørgård, B M, Nielsen, J, Fonager, K, Kjeldsen, J, Jacobsen, B A & Qvist, N 2014, ' The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012)-Based on nationwide Danish registry data ', Journal of Crohn's and Colitis, vol. 8, no. 10, pp. 1274-1280 . https://doi.org/10.1016/j.crohns.2014.03.006
Background and aims : The incidence of ulcerative colitis (UC) and Crohn's disease (CD) has increased during the 20th century in North America and Western Europe. However, there are conflicting reports whether the incidence has declined, stabilized o
Publikováno v:
Larsen, L, Drewes, A M, Fallingborg, J, Jacobsen, B A & Jess, T 2016, ' Touch screens as a tool in patient care in the IBD outpatient clinic ', Scandinavian Journal of Gastroenterology, vol. 51, no. 9, pp. 1106-1110 . https://doi.org/10.1080/00365521.2016.1174879
OBJECTIVE: We have introduced online touch screens in the waiting room for patients with ulcerative colitis (UC) or Crohn's disease (CD) for recording of symptoms before their consultation. This has made disease activity scores readily available to t
Autor:
Ulla Vogel, Anja Ernst, Jack Satsangi, Mette Østergaard, Bent Ascanius Jacobsen, Gwo-Tzer Ho, Charlie W. Lees, Jane Christensen, Elaine R. Nimmo, Henrik Krarup, Vibeke Andersen, Hazel E. Drummond
Publikováno v:
Andersen, V, Nimmo, E, Krarup, H B, Drummond, H, Christensen, J, Ho, G, Ostergaard, M, Ernst, A, Lees, C, Jacobsen, B A, Satsangi, J & Vogel, U 2011, ' Cyclooxygenase-2 (COX-2) Polymorphisms and Risk of Inflammatory Bowel Disease in a Scottish and Danish Case-Control Study ', Inflammatory Bowel Diseases, vol. 17, no. 4, pp. 937-46 . https://doi.org/10.1002/ibd.21440
Andersen, V, Nimmo, E, Krarup, H B, Drummond, H, Christensen, J, Ho, G-T, Ostergaard, M, Ernst, A, Lees, C, Jacobsen, B A, Satsangi, J & Vogel, U B 2011, ' Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study ', Inflammatory Bowel Diseases, vol. 17, no. 4, pp. 937-946 . https://doi.org/10.1002/ibd.21440
Andersen, V, Nimmo, E, Krarup, H B, Drummond, H, Christensen, J, Ho, G-T, Ostergaard, M, Ernst, A, Lees, C, Jacobsen, B A, Satsangi, J & Vogel, U B 2011, ' Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study ', Inflammatory Bowel Diseases, vol. 17, no. 4, pp. 937-946 . https://doi.org/10.1002/ibd.21440
Background: Inflammatory bowel diseases (IBDs) are a result of interactions between luminal pathogens and the intestinal immune response. Cyclooxygenase-2 (COX-2) plays a key role in the regulation of the inflammatory response upon stimulation by lum
Autor:
Henrik Okkels, Bent Ascanius Jacobsen, Asbjørn Mohr Drewes, Vibeke Andersen, Henrik Krarup, Mette Østergaard, Anja Ernst, Inge Søkilde Pedersen, Enrika Dagiliene
Publikováno v:
Ernst, A, Østergaard, M, Jacobsen, B A, Dagiliene, E, Pedersen, I S, Drewes, A, Okkels, H, Andersen, V & Krarup, H B 2010, ' Genetic variants of glutathione S-transferases mu, theta, and pi display no susceptibility to inflammatory bowel disease in the Danish population ', Scandinavian Journal of Gastroenterology. Supplement, vol. 45, no. 9, pp. 1068-1075 . https://doi.org/10.3109/00365521.2010.490594
Ernst, A, Andersen, V, Østergaard, M, Jacobsen, B A, Dagiliene, E, Pedersen, I S, Drewes, A M, Okkels, H & Krarup, H B 2010, ' Genetic variants of glutathione S-transferases mu, theta, and pi display no susceptibility to inflammatory bowel disease in the Danish population ', Scandinavian Journal of Gastroenterology, vol. 45, no. 9, pp. 1068-75 . https://doi.org/10.3109/00365521.2010.490594
Ernst, A, Andersen, V, Østergaard, M, Jacobsen, B A, Dagiliene, E, Pedersen, I S, Drewes, A M, Okkels, H & Krarup, H B 2010, ' Genetic variants of glutathione S-transferases mu, theta, and pi display no susceptibility to inflammatory bowel disease in the Danish population ', Scandinavian Journal of Gastroenterology, vol. 45, no. 9, pp. 1068-75 . https://doi.org/10.3109/00365521.2010.490594
Udgivelsesdato: 2010 Abstract Introduction. A combination of genetic predisposition and interactions with environmental factors are believed to be responsible for disease phenotype and disease progression in inflammatory bowel diseases. The harmful e